Bio-Techne

173 articles with Bio-Techne

• Bio-Techne To Host Conference Call On October 29, 2019, To Announce First Quarter 2020 Financial Results

  10/8/2019

  Bio-Techne Corporation announced that management will host a conference call on Tuesday, October 29, 2019, at 8:00 a.m. CDT to review first quarter 2020 financial results.

• Bio-Techne Attains ISO 9001:2015 Certification for Fetal Bovine Serum Manufacturing Facility

  9/16/2019

  This certification demonstrates Bio-Techne's commitment for providing high-quality serum and media that aligns with the quality excellence standards preferred by biotech, biopharmaceutical and pharmaceutical companies as well as academic researchers.

• Bio-Techne Introduces Maurice Empower® Control Kit For The Maurice™ System

  8/20/2019

  This new kit enables users to collect, manage and report Maurice results with the industry leading Empower® 3 Software from Waters™ Corporation.

• Bio-Techne And Cygnus Technologies Announce Partnership For 3G CHO-HCP Assay

  8/13/2019

  Bio-Techne Corporation and Cygnus Technologies, part of Maravai LifeSciences, announced today a strategic partnership for the quantification of Chinese hamster ovary host cell proteins (CHO-HCP) on the ProteinSimple™-branded Ella™ immunoassay platform.

• Bio-Techne Releases Fourth Quarter Fiscal 2019 Results

  8/6/2019

  Bio-Techne Corporation reported its financial results for the fourth quarter ended June 30, 2019.

• Bio-Techne Declares Dividend payable August 30, 2019

  8/6/2019

  Bio-Techne Corporation announced that its Board of Directors has decided to pay a dividend of $0.32 per share for the quarter ended June 30, 2019.

• Uman Diagnostics And Bio-Techne Announce License And Supply Agreement For Neurofilament Light Assay

  7/23/2019

  Under the terms of the agreement, Uman Diagnostics will supply Nf-L antibodies to Bio-Techne for use in its proprietary Simple Plex™ immunoassays on Ella.

• Bio-Techne To Host Conference Call On August 6, 2019, To Announce Fourth Quarter 2019 Financial Results

  7/18/2019

  CDT to review fourth quarter 2019 financial results.

• Bio-Techne Releases 32x8 Cartridge For The Ella Platform

  7/17/2019

  This new cartridge format analyzes 32 samples for eight distinct analytes, bringing higher multiplex capabilities to the Ella platform.

• Bio-Techne Announces Commercial Release Of RNAscope® HiPlex Assay: A Multiplex In Situ Hybridization Assay For Tissues

  7/11/2019

  Expanding research tools for Spatial Genomics by combining molecular information with spatial context in one simple assay.

• Bio-Techne China Recognized With "Decade of Contribution Award"

  6/26/2019

  This award recognized the commitment of Bio-Techne's team in China to providing comprehensive support and reliable products and services for the Chinese Biotechnology industry.

• Bio-Techne Receives Approval To Offer The ExoDx™ Prostate Intelliscore™ (EPI) Test In New York State

  6/13/2019

  Bio-Techne today announced that it has received a clinical laboratory permit from the New York State Department of Health to provide its ExoDx Prostate IntelliScore (EPI) test in New York, providing a valuable tool to help Urologists rule out unnecessary prostate biopsies.

• Bio-Techne To Acquire B-MoGen Biotechnologies Inc.

  6/4/2019

  Bio-Techne Corporation announced it has reached agreement to acquire all of the stock of B-MoGen Biotechnologies Inc.

• Bio-Techne's New Exosome-Based Liquid Biopsies Helping To Advance Personalized Care In Lung Cancer Diagnostics

  5/28/2019

  Bio-Techne announced the publication of a recent validation study demonstrating that the proprietary exosome-based liquid biopsy tests from Bio-Techne's Exosome Diagnostics brand may be used to assess the mutational status of the Epidermal Growth Factor Receptor gene in patients with non-small cell lung cancer.

• Bio-Techne To Present At The Jefferies 2019 Global Healthcare Conference

  5/21/2019

  Bio-Techne Corporation announced that Chuck Kummeth, President and Chief Executive Officer, will present at the Jefferies 2019 Global Healthcare Conference on Wednesday, June 5th, 2019, at 9:30 a.m. EDT.

• Bio-Techne To Present At The UBS Global Healthcare Conference

  5/14/2019

  The conference will be held at the Grand Hyatt Hotel in New York City.

• Roche expands partnership with Bio-Techne to offer drug discovery researchers new chromogenic detection options for mRNA ISH tissue analysis

  5/6/2019

  New Roche detection kits, combined with Bio-Techne's ACD RNAscope® reagent kits, increase singleplex and multiplex testing capabilities on automated platform

• Bio-Techne To Present At The Bank Of America Merrill Lynch 2019 Health Care Conference

  5/2/2019

  Bio-Techne Corporation announced that Jim Hippel, Chief Financial Officer will present at the Bank of America Merrill Lynch 2019 Health Care Conference on Wednesday, May 15th, 2019, at 2:20 p.m. PDT.

• Bio-Techne Releases Third Quarter Fiscal 2019 Results

  4/30/2019

  Bio-Techne Corporation reported its financial results for the third quarter ended March 31, 2019.

• Bio-Techne Declares Dividend payable May 24, 2019

  4/30/2019

  Bio-Techne Corporation announced that its Board of Directors has decided to pay a dividend of $0.32 per share for the quarter ended March 31, 2019.